Spatio-temporal signaling mechanism of protein kinase C
Spatio-temporal signaling mechanism of protein kinase C
批准号:
13470023
负责人:
SAITO Naoaki
金额:
$7.49万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
PKC由10多种异构体组成,多种异构体的存在强烈表明每种异构体在信号转导中具有单独的功能作用。我们利用绿色荧光蛋白(GFP)标记的PKC异构体,研究了PKC的“何时、何地、哪种异构体被激活以及激活如何调节细胞功能”。我们发现PKC易位在活细胞中是动态和可逆的,PKC靶向是异构体特异性、刺激特异性和细胞特异性的。在本研究中,我们已经证明了1)烯四烯酸和神经酰胺作用于epsilon和deltaPKC的CIB结构域,并以特定的方式将这些PKC异构体转运到高尔基复合体上,2)神经酰胺诱导deltaPKC转运到高尔基复合体上,并通过酪氨酸磷酸化激活PKC异构体。(3)神经酰胺激活deltaPKC导致细胞凋亡,这与PKC的另一种激活剂磷酸酯诱导的细胞凋亡有明显不同。4)内源性PKC可以被siRNA特异性地敲除异构体和物种。5)多种PKC亚型参与小胶质细胞的吞噬作用。最后,我们利用四环素调控系统生产了表达gfp标记PKC亚型的转基因小鼠。PKC-GFP的表达受时空调控。这些转基因小鼠使我们能够在生理条件下监测PKC在脑切片中的靶向性,我们观察到PKC在活脑中的易位与在培养细胞中观察到的不同。
英文摘要
PKC consists of more than 10 isoforms and the existence of multiple isoforms strongly suggests that each isoform has individual functional role in signal transduction. We have been investigated "When, Where, Which isoform of PKC is activated and How the cellular function is regulated by the activation" by using green fluorescent protein(GFP)-tagged PKC isoforms. We have found that PKC translocation is dynamic and reversible in living cells and that PKC targeting is isoform-specific, stimulus-specific and cell-specific.In the present study, we have demonstrated that 1) arachidonic acid and ceramide act on CIB domains of epsilon and delta PKC and translocate these PKC isoforms to Golgi complex in isoform-specific manner, 2) ceramide induces translocation of deltaPKC to Golgi complex and activates this PKC isoform through tyrosine-phosphorylation., 3) Activation of deltaPKC by ceramide results in apoptosis which is distinctly different cell response from that induced by phorbol ester, another activator of PKC., 4) endogenous PKC can be knock-down by siRNA in isoform and species specifically., 5) Multiple PKC isoforms are involved in phagocytosis of microglial cells. Finally, we produced transgenic mice expressing GFP-tagged PKC isoforms using tetracyclin-regulated system. The expression of PKC-GFP can be regulated spatially and temporally. These transgenic mice enable us to monitor PKC targeting in brain slices by physiological condition and we observed PKC translocation in living brain which was different from that observed in cultured cells.
期刊论文(144)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Takehiko Ueyama: "Constitutively active fragment of PKN in microglia/macrophage after middle cerebral artery occlusion in rat"J. Neurochem.. 79. 903-913 (2001)
Takehiko Ueyama:“大鼠大脑中动脉闭塞后小胶质细胞/巨噬细胞中 PKN 的组成型活性片段”J。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Larsen 他: "Role for PKC-ε in FcgR-mediated phagocytosis by RAW 264.7 cells"J.Cell Biol.. 159. 939-944 (2002)
Larsen 等人:“PKC-ε 在 RAW 264.7 细胞 FcgR 介导的吞噬作用中的作用”J.Cell Biol.. 159. 939-944 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Taketoshi Kajimotoh 他: "Subtype-specific translocation of the δ subtype of protein kinase C and its activation by tyrosine phosphorylation by ceramide in HeLa cells"Mol.Cell.Biol.. 21. 1769-1783 (2001)
Taketoshi Kajimotoh 等人:“HeLa 细胞中蛋白激酶 C δ 亚型的亚型特异性易位及其通过神经酰胺酪氨酸磷酸化的激活”Mol.Cell.Biol.. 21. 1769-1783 (2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kohjima M, et al.: "PAR3beta, a novel homologue of the cell polarity protein PAR3, localizes to tight junctions"Biochem Biophys Res Commun. 299. 641-646 (2002)
Kohjima M 等人:“PAR3beta 是细胞极性蛋白 PAR3 的一种新型同源物,定位于紧密连接”Biochem Biophys Res Commun。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Katsuyuki Mishima: "Molecular mechanisms for α2-adrenoceptor-mediated regulation of synoviocytes populations"Jpn.J.Pharmacol.. 85. 214-226 (2001)
Katsuyuki Mishima:“α2-肾上腺素受体介导的滑膜细胞群调节的分子机制”Jpn.J.Pharmacol.. 85. 214-226 (2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 57 条
Production and analysis of model animals for neurodegenerative diseases caused by dysfunction of PKC and their use for drug design
-
批准号:21390070
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.9万
-
财政年份:2009
-
负责人:SAITO Naoaki
-
依托单位:
Mechanism and treatment for the disease caused by the impairment of PKC signaling
-
批准号:19390064
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.31万
-
财政年份:2007
-
负责人:SAITO Naoaki
-
依托单位:
Molecular mechanism of cellular response induced by dynamic metabolism of membrane phospholipid
-
批准号:17390065
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.34万
-
财政年份:2005
-
负责人:SAITO Naoaki
-
依托单位:
Pharmacogenomic research for mood disorder
-
批准号:12558089
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.17万
-
财政年份:2000
-
负责人:SAITO Naoaki
-
依托单位:
Research for modulation of expression of serotonin transporter and its involvement in mental disorder
-
批准号:09670091
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:1997
-
负责人:SAITO Naoaki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
-
批准号:82373145
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:历鹏
-
依托单位:
诱导性多能干细胞rDNA区基因打靶在线粒体视神经病中的治疗研究
-
批准号:81970829
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:李卓
-
依托单位:
Pre-targeting/Click反应介导的自体循环干细胞在心脏缺血损伤修复中的应用及机制研究
-
批准号:81873493
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:沈德良
-
依托单位:
以IGF2/IGF1R与SYT/SSX1为靶点治疗滑膜肉瘤的实验研究
-
批准号:81102033
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2011
-
负责人:李大森
-
依托单位:
基于ZFN/phiC31系统的新型基因打靶技术的建立(果蝇)
-
批准号:31171278
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:高冠军
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: